Jason S Starr (Jason Starr)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Decision Making

Childhood Cancer

Top Venues

JCO precision oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Derk C F Klatte, Jason S Starr, Kristin E Clift, Heather D Hardway, Jeanin E van Hooft, Monique E van Leerdam, Thomas P Potjer, Richard John Presutti, Douglas L Riegert-Johnson, Michael B Wallace, Yan Bi
Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma. JCO oncology practice (2024)
Yael N Kusne, Terra Lasho, Christy Finke, Zaid Elsabbagh, Shaylene McCue, Timothy J Hobday, Jason S Starr, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson, Mirinal S Patnaik, Fang-Shu Ou, Mohamad Bassam B Sonbol
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study. JCO precision oncology 8 (2024)
Derk C F Klatte, Jason S Starr, Kristin E Clift, Heather D Hardway, Jeanin E van Hooft, Monique E van Leerdam, Thomas P Potjer, Richard John Presutti, Douglas L Riegert-Johnson, Michael B Wallace, Yan Bi
Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma. JCO oncology practice 20 (8) (2024)
Tucker W Coston, Aakash P Desai, Hani M Babiker, Mohamad Bassam B Sonbol, Sakti Cjakrabarti, Amit Mahipal, Robert R McWilliams, Wen Wee Ma, Tanios S Bekaii-Saab, John A Stauffer, Jason S Starr
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience. JCO precision oncology 7 (2023)
Pashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, Jason S Starr, Pedro C Barata, Samuel J Klempner, David R Gandara, Ardaman Shergill, Luciana Madeira da Silva, Caroline Weipert, Nicole Zhang, Christopher Pretz, Aaron I Hardin, Lesli A Kiedrowski, Justin I Odegaard
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes. JCO precision oncology 7 (2023)
Pedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam B Sonbol, Daniel H Ahn, Jason S Starr, Jeremy C Jones, Hani M Babiker, Samantha R Inabinett, Natasha Wylie, Ashton W R Boyle, Tanios S Bekaii-Saab, Gregory J Gores, Rory Smoot, Michael Barrett, Bolni Marius Nagalo, Nathalie Meurice, Natalie M Elliott, Joachim Petit, Yumei Zhou, Mansi Arora, Chelsae Dumbauld, Oumar Barro, Alexander T Baker, James Bogenberger, Kenneth H Buetow, Aaron S Mansfield, Kabir Mody, Mitesh J Borad
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 6 (2022)